Trauma Care Articles & Analysis: Older
4 news found
The therapeutic product would be administered and be designed to mitigate risks of antibiotic-resistant infections in resource constrained settings such as battlefield medicine and trauma care. Preclinical in vivo studies demonstrate Lumen’s therapeutic approach could be effective in preventing and treating infections caused by antibiotic resistant ...
"As a result, there is a need for a field deployable, minimally invasive, and effective tool to prevent exsanguination and aid in the urgent care of those wounded. This is core to Amsel's mission - saving limbs and saving lives for both those who serve, and to serve the broader public's need for improved trauma care." ...
Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
While disruptive technologies have the potential to enhance infrastructure and care delivery, adoption of same has been restricted due to a number of factors like affordability, knowledge about its clinical utility, distribution, service, funding etc. ...